Cyanoflan: versatile biomaterial for wound healing and skincare applications
Cyanoflan is a bio-based, naturally produced polymer with antioxidant and anti-inflammatory properties, ideal for skincare and pharmaceutical applications. It supports wound healing and can serve as a thickening and stabilizing agent, appealing to eco-conscious consumers.
Overview
Cyanoflan is an innovative biomaterial derived from a natural production process requiring only saltwater, inorganic nutrients, light, and aeration. This extracellular polymer boasts significant advantages due to its anti-inflammatory and antioxidant properties, making it particularly suited for skincare and pharmaceutical applications. Cyanoflan has shown promising results in promoting wound healing and reducing inflammation, making it a valuable addition to personal care products targeting eco-conscious consumers who prefer natural over synthetic ingredients.
Technical specifications
Cyanoflan is primarily constituted by heteropolysaccharides with a high molecular mass and a highly branched chemical structure. Notably, it does not require genetic or chemical modifications for production. Its key features include:
- Antioxidant Activity: Reduces reactive oxygen species production in endothelial cells.
- Anti-inflammatory Effects: Demonstrated reduction in pro-inflammatory markers in wound healing assays.
- Versatility: Functions as a thickener, texturizer, and emulsion stabilizer in cosmetic and pharmaceutical formulations.
- Biocompatibility: Supports the migration and proliferation of crucial skin cells, aiding in wound healing.
Technology readiness level
Cyanoflan has reached a Technology Readiness Level (TRL) of 4. It has been extensively characterized and validated in laboratory settings, including successful wound healing assays in animal models. Current efforts are focused on optimizing industrial-scale production to further advance its commercial viability.
About Austrian Centre of Industrial Biotechnology
The Austrian Centre of Industrial Biotechnology (acib) is a privately owned, non-profit research center based in Graz with about 200 staff and a multi‑site footprint across Austria (Graz, Vienna, Innsbruck, Tulln, Linz). It connects industry and academia through an open‑innovation platform and embedded partnerships with leading universities, providing a one‑stop interface that streamlines project scoping and execution. Its locations position acib within Austria’s major life‑science clusters, notably Styria and Vienna, giving partners access to talent and shared infrastructure. Research is funded through Austria’s COMET program (FFG) with support from national ministries and regional states; acib operates as a COMET K2 center. Collaboration is delivered via contract R&D with clear confidentiality and IP handling to accelerate translation.
delivered to your inbox.